Supporting a CAR-T Therapy for Multiple Myeloma with Integrated Laboratory Testing and Clinical Expertise

An emerging biotech sponsor chose Labcorp to support clinical testing and trials in their early-phase multiple myeloma study with a novel CAR-T therapy. Learn how the sponsor extended their team's expertise - through the Labcorp multiple myeloma team and CAR-T working group - and recognized the benefits of an integrated approach that united both laboratory services and clinical trial support to increase transparency and gain efficiencies across their portfolio.

Filed In

Labs & Centralized Testing
Multiple Myeloma